Indivior PLC

Report Publication Announcement • Nov 4, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2085S

Indivior PLC

04 November 2019

Indivior to Participate in Upcoming Investor Conferences

Slough, UK, and Richmond, VA - 4 November 2019 - Indivior PLC (LON: INDV) today announced that it will participate in the following Investor Conferences the week of November 18th. The presentations along with the live audio webcast will be available on the "Investors" section of the company's website at www.indivior.com.  All indicated times are local.

·      2019 Stifel Healthcare Conference (New York City)- November 19th, 1:15 PM - Shaun Thaxter , CEO

·      Jefferies 2019 London Healthcare Conference (London)- November 21st, 11:20 AM - Shaun Thaxter, CEO

About Indivior

Indivior is a global specialty pharmaceutical company with a 20-year legacy of leadership in patient advocacy and health policy while providing education on evidence-based treatment models that have revolutionized modern addiction treatment. Our vision is for all patients around the world to have access to evidence-based treatment for the chronic conditions and co-occurring disorders of addiction. The name is the fusion of the words individual and endeavor, and the tagline "Focus on you" makes the Company's commitment clear. Indivior is dedicated to transforming addiction from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of opioid dependence treatments, Indivior has a strong pipeline of product candidates designed to both expand on its heritage in this category and address other chronic conditions and co-occurring disorders of addiction, including alcohol use disorder and schizophrenia. Headquartered in the United States in Richmond, VA, Indivior employs more than 800 individuals globally and its portfolio of products is available in over 40 countries worldwide. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/indivior. 

Media Contacts:

US

IndiviorMediaContacts@indivior.com

+1 804-594-0836

UK

Tulchan Communications

+44 207-353-4200

Investor Contact:

Jason Thompson, Indivior

Vice President, Investor Relations

+1 804-402-7123

Jason.Thompson@indivior.com

-ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

MSCEASFLEDNNFFF